Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

PharmaEngine Inc

+ Add to Watchlist

4162:TT

278.00 TWD 3.50 1.28%

As of 01:31:47 ET on 03/04/2015.

Snapshot for PharmaEngine Inc (4162)

Open: 275.00 Day's Range: 275.00 - 283.00 Volume: 1,485,795
Previous Close: 274.50 52wk Range: 180.00 - 355.00 1-Yr Rtn: +3.73%

Stock Chart for 4162

No chart data available.
  • 4162:TT 278.00
  • 1D
  • 1M
  • 1Y
274.50
Interactive 4162 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4162

Current P/E Ratio (ttm) 205.9870
Estimated P/E(12/2014) 254.1133
Relative P/E vs. TWOTCI 7.2340
Earnings Per Share (TWD) (ttm) 1.3496
Est. EPS (TWD) (12/2014) 1.0940
Est. PEG Ratio -
Market Cap (M TWD) 28,306.24
Shares Outstanding (M) 101.82
30 Day Average Volume 635,298
Price/Book (mrq) 9.5919
Price/Sale (ttm) 119.3472
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4162

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4162

PharmaEngine, Inc. operates as a biopharmaceutical company. The Company focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases.

Lin Jung-ChinChairmanGrace C YehPresident/CEO
Chang Chi-HsingVice President:Financial
More Company Profile & Key Executives for 4162

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil